ライフサイエンスコーパス: xyloside

1 nt cells as well as in WT cells treated with xyloside.

2 or by treatment of WT cells with heparin or xyloside.

3 th 20 or 50 mM sodium chlorate, or 1 mM beta-xyloside.

4 case of the beta-mannoside than of the beta-xyloside.

5 We previously reported that the xyloside 2-(6-hydroxynaphthyl) beta-d-xylopyranoside (Xy

6 porcine eyes with chlorate (3-fold) and beta-xyloside (3.5-fold) treatments.

7 erein we report the discovery of the novel O-xyloside 7c that inhibits SGLT2 in vitro and urinary glu

8 uman gene C3ORF21 encodes a UDP-xylose:alpha-xyloside alpha1,3-xylosyltransferase, acting on xylose-a

9 the core proteins of proteoglycans by beta-d-xylosides also reduced incorporation of LTBP1 into the E

10 vity of the glycoside, we synthesized beta-D-xyloside analogs in which the hydroxyls were substituted

11 signing inhibitors of GAG synthesis based on xyloside analogs with reactive groups in key positions.

12 on fibrinogen were inhibited by both beta-d xyloside and after cleavage of chondroitin sulfate from

13 hat these differ in composition depending on xyloside and cell type, detailed knowledge regarding a s

14 ation, two more ACNs (cyanidin-3-galactoside-xyloside and cyanidin-3-galactoside-xyloside-glucoside-s

15 d as N-(4-methoxyphenyl)formamide 2-O-beta-D-xyloside and was revealed to have the potential to enhan

16 ontribute to the discrimination between beta-xylosides and beta-glucosides.

17 ein glycoform, the addition of benzyl-beta-d-xyloside, and a UDP-xylose: core protein beta-d-xylosylt

18 sulfate side chain formation inhibitor beta-xyloside, and soluble heparin on the overexpression of p

19 We surmise that click-xylosides are differentially recognized by the GAGOSOMES

20 ta-D-glucosides, beta-D-galactosides, beta-L-xylosides, beta-D-arabinosides), similar to the native e

21 by assaying the transfer of galactose to the xylosides by galactosyltransferase I (UDP-D-galactose:xy

22 highlighted a subnetwork including two novel xylosides (compounds 2 and 3).

23 ells also will assemble GAG chains on beta-D-xylosides containing hydrophobic aglycones.

24 l-beta-D-xyloside, reduced the amount of the xyloside-CS chains by 65.4 and 87.0%, respectively.

25 The size of xyloside-CS chains synthesized in the presence of 4-F-Gl

26 cterized by its unique capacity to take over xyloside derivatives linked to a hydrophobic aglycone as

27 -h incubation in 4-methylumbelliferyl-beta-D-xyloside did not attenuate the ability of LPL to reduce

28 anthocyanin compound, followed by cyanidin-3-xyloside-galactoside (C3XG, 49.56-70.12mg/L).

29 nds from black carrot pomace with cyanidin-3-xyloside-galactoside-glucoside-ferrulic acid (C3XGGF, 60

30 ajor ACN, followed by cyanidin-3-galactoside-xyloside-glucoside-coumaric acid, and cyanidin-3-galacto

31 arified BCJ contained cyanidin-3-galactoside-xyloside-glucoside-ferulic acid as the major ACN, follow

32 actoside-xyloside and cyanidin-3-galactoside-xyloside-glucoside-sinapic acid) were also identified.

33 de-coumaric acid, and cyanidin-3-galactoside-xyloside-glucoside.

34 the PDGF effect, but not in the presence of xyloside, indicating that GAG synthesis that results fro

35 This conclusion was based on beta-xyloside inhibition of glycanation and specific glycosam

36 It was active on p-nitrophenyl-alpha-d-xyloside, isoprimeverose, xyloglucan heptasaccharide (XX

37 try revealed that the active principles were xylosides of dimethylated ellagic acid.

38 These novel click-xylosides offer new avenues to profile the cell-specific

39 Second, beta-xyloside or monensin, reagents that inhibit the synthesi

40 paran sulfate side chain formation with beta-xyloside or the addition of soluble heparin prevented ER

41 lycan synthesis (4-methylumbelliferyl-beta-D-xyloside) or sulfation (sodium chlorate) enhanced the re

42 Treatment with either U0126, beta-xyloside, or heparin resulted in a reduction in the over

43 dications that this could be mediated by the xyloside-primed glycosaminoglycans (GAGs) and that these

44 of CS synthesis, 4-methylumbelliferyl-beta-D-xyloside, reduced the amount of the xyloside-CS chains b

45 treated with chlorate or substituted beta-D-xylosides, resulting in undersulfation or secretion of G

46 inhibition of endogenous PG biosynthesis by xyloside significantly attenuated exosome uptake.

47 Priming by these unusual xylosides suggests the possibility of designing inhibito

48 We have utilized a library of click-xylosides that have various aglycones to decipher the me

49 OPCs and by treating demyelinated mice with xyloside to reduce the CSPG deposition that occurred fol

50 bronectin immunostaining was altered in beta-xyloside-treated eyes, whereas in cell culture, chlorate

51 Ac were only slightly larger than those with xyloside treatment alone (K(av) of 0.55 compared with th

52 Finally, in vivo xyloside treatment to reduce CSPG synthesis in lysolecit

53 toside, peonidin-3-O-glucoside, cyanidin-3-O-xyloside were separated and identified by LC/DAD/MS and

54 hlorate, an inhibitor of sulfation, and beta-xyloside, which provides a competitive nucleation point

55 -keto derivative) and benzyl-4-methyl-beta-D-xyloside, with a methyl group in place of an axial hydro

56 p-nitrophenyl beta-d xylopyranoside (beta-d xyloside), wound microvascular endothelial cells were ca

57 mbination of the food components vitexin-2-O-xyloside (X), raphasatin (4-methylsulphanyl-3-butenyl is

58 Vitexin-2-O-xyloside (XVX) from Beta vulgaris var. (BVc) seeds, beta

59 Vitexin-2-O-xyloside (XVX) from Beta vulgaris var. cicla L. (BVc) se

60 cubation of these cells with naphthol-beta-D-xyloside (Xylbeta-O-Np) resulted in accumulation of link

61 Finally, a UDP-xylose:xyloside xylosyltransferase (Xxylt1) transfers xylose to

62 We have, therefore, renamed it XXYLT1 (xyloside xylosyltransferase 1).